$6.36 $0.86 (15.6%)

01:16 PM EDT on 06/17/19

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)

CAPS Rating: No stars

Current Price $6.36 Mkt Cap $253.8M
Open $5.51 P/E Ratio 0.00
Prev. Close $5.50 Div. (Yield) $0.00 (0.0%)
Daily Range $5.51 - $6.52 Volume 11,719
52-Wk Range $5.17 - $9.85 Avg. Daily Vol. 4

Caps

How do you think NASDAQ:SYRS will perform against the market?

Add Stock to CAPS Watchlist

All Players

1 Outperform
3 Underperform
 

All-Star Players

0 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SYRS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

SmartAce (99.97)
Submitted March 18, 2019

I miss those two years in the nineties when instead of using sarcasm we’d just say the opposite of what we were thinking followed by “NOT”

NASDAQ:SYRS VS S&P 500 (SPY)

NASDAQ:SYRS Summary

Recent Community Commentary

Read the most recent pitches from players about SYRS.

Recs

1
Member Avatar SmartAce (99.97) Submitted: 3/18/2019 1:54:07 PM : Underperform Start Price: $8.93 NASDAQ:SYRS Score: +34.32

I miss those two years in the nineties when instead of using sarcasm we’d just say the opposite of what we were thinking followed by “NOT”

Leaderboard

Find the members with the highest scoring picks in SYRS.

Score Leader

chushogi

chushogi (67.97) Score: +80.11

The Score Leader is the player with the highest score across all their picks in SYRS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
chushogi 67.97 1/9/2017 Underperform 5Y $12.86 -52.41% +27.70% +80.11 0 Comment
Gvozden 99.86 3/18/2019 Underperform 5Y $9.02 -32.15% +2.72% +34.87 0 Comment
SmartAce 99.97 3/18/2019 Underperform 5Y $8.93 -31.47% +2.85% +34.32 1 Comment
HDTVBG < 20 6/13/2019 Outperform 3W $6.01 +1.83% +0.17% +1.66 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SYRS.

Advertisement